Other upcoming conferences produced by EOCI include:

Congress Learning Objectives

Following the program, participants will be able to:

  • Identify early opportunities to advance evidence based treatments for patients with decompensated heart failure
  • Recognize and treat infiltrative cardiac diseases such as amyloidosis
  • Utilize advanced imaging to help manage heart failure due to ischemia, pump failure or valvular dysfunction
  • Better recognize the HFpEF syndrome and its accompanying conditions

Plenary Session: There’s No Time Like the Right Time: Optimal Heart Failure Therapy Before, During and After Hospitalization

What evidence do we have to start evidence-based drugs in hospital?

Nadia Giannetti, MD

Following this session, participants will be better able to:

  1. Review the limitations of current heart failure management
  2. Discuss the risks and benefits of in-hospital initiation of heart failure therapy
  3. Review the evidence to support in-hospital initiation of heart failure therapy

Population precision medicine and the prevention of heart failure

Sean Virani, MD

Following this session, participants will be better able to:

  1. Understand risk stratification for ambulatory & decompensated HF patients
  2. Describe disease indicators that can help guide treatment decisions
  3. Discuss tools to predict which patients are best served by disease management strategies

Ensuring timely optimization of heart failure care

Robert McKelvie, MD

Following this session, participants will be better able to:

  1. Examine the current and future state of outpatient HF management in Canada
  2. Discuss effective strategies for the rapid optimization of HF therapies
  3. Review contemporary strategies for the prevention of HF

Should we consider "rescue" CRT?

Isabelle Nault, MD

Following this session, participants will be better able to:

  1. Understand the role of CRT in "end-stage HF"
  2. Identify in-patients in whom CRT should be avoided
  3. Describe the need for any special preparations that should be made for in-hospital CRT

Plenary Session: Imaging for the Heart Failure Patient: Pump, Perfusion or Special Testing

Don't go breaking my heart: Imaging and prognosis in Takotsubos

Peter Liu, MD

Following this session, participants will be better able to:

  1. Describe the role of angiography and cardiac imaging in the diagnosis of Takotsubos
  2. Understand the implications of Takotsubos and the need for long-term follow-up
  3. Discuss the role of imaging in the determination of long-term therapies for Takotsubos

Imaging for acute vs chronic myocarditis

Matthias Friedrich, MD

Following this session, participants will be better able to:

  1. Describe a diagnostic algorithm for acute myocarditis
  2. Discuss the role of imaging in distinguishing acute vs. chronic myocarditis
  3. Examine strategies for the long-term follow-up of myocarditis using current imaging modalities

How to identify the right and wrong patient for percutaneous mitral intervention

Anita Asgar, MD

Following this session, participants will be better able to:

  1. Discuss discrepant results that have been reported in recent mitral intervention studies
  2. Understand the diagnostic pathway for determining patient eligibility for percutaneous mitral interventions
  3. Review the routine follow-up of patients post-mitral clip procedures

To revascularize or not to revascularize: Imaging for decision-making in ischemic cardiomyopathy

Lisa Mielniczuk, MD

Following this session, participants will be better able to:

  1. Identify potential pitfalls of imaging in patients with HF
  2. Delineate the role of multimodal imaging for the diagnosis of ischemic cardiomyopathy
  3. Describe the use of imaging to help determine the risk of revascularization

Plenary Session: HFpEF and Beyond! Novel Concepts in HFpEF and HFrEF

Invasive measurement: The new gold standard for diagnosis of HFpEF?

Susanna Mak, MD

Following this session, participants will be better able to:

  1. Describe the utility of currently used diagnostic algorithms for HFpEF
  2. Understand the rationale for using exercise stress testing for the diagnosis of HFpEF
  3. Discuss the role of invasive exercise testing in the context of cardiopulmonary or exercise echo testing

The nuts & bolts of real world implantable hemodynamic monitoring

Brian Clarke, MD

Following this session, participants will be better able to:

  1. Describe the rationale for implantable hemodynamic monitoring
  2. Identify patient populations that may benefit from implantable hemodynamic monitoring
  3. Understand the process of care that supports the use of this technology

Managing fluid, salt, K+ and creatinine in heart failure or cardiorenal syndrome

Serge Lepage, MD

Following this session, participants will be better able to:

  1. Understand the interaction of diabetes, kidney disease and HF
  2. Review the management of potassium, the "forgotten ion"
  3. Understand established & new modalities for the treatment of potassium disorders

Rapidfire update: New heart failure therapies & late breaking trials for HFrEF and HFpEF

Justin Ezekowitz, MB BCh

Following this session, participants will be better able to:

  1. Discuss what's new in HFrEF and HFpEF in the past year
  2. Review trials of HFrEF and HFpEF therapies that will be reporting results in the next year
  3. Examine what's on the horizon for HFrEF and HFpEF beyond 2019

Canadian Heart Failure Society (CHFS) & Heart Failure Society of America (HFSA) joint symposium:
Can Amyloid Heart Disease Be Beat?

When is LVH not just LVH? Practical clinical algorithms when you suspect amyloid

Mazen Hanna, MD

Following this session, participants will be better able to:

  1. Identify red flags for unexplained LVH
  2. Discuss when to suspect amyloid with noncardiac symptoms
  3. Describe a practical algorithm for the workup of unexplained LVH

AL Amyloid: “The Other Guys”

Margot Davis, MD

Following this session, participants will be better able to:

  1. Review the presentation of AL amyloid including the conditions associated with it
  2. Differentiate the presentation & clinical course of AL amyloid from TTR-amyloid
  3. Discuss treatment options for AL amyloid

When ATTR gets on your nerves: A primer on ATTR neurologic involvement for cardiologists

Angela Genge, MD

Following this session, participants will be better able to:

  1. Review the heterogeneity in the presentation of ATTR
  2. Describe neurologic complications associated with ATTR
  3. Discuss clinical presentations where a neurologist should be consulted

Promising therapies on the horizon for TTR Amyloid

Nowell Fine, MD

Following this session, participants will be better able to:

  1. Discuss the use of RNA "silencers" for the treatment of TTR amyloid
  2. Describe TTR-amyloid stabilizer therapies
  3. Examine the use of "degrader" therapies for TTR amyloid

Workshops

Nursing workshop: Heart failure in the frail and elderly (in French)

Kim Laflamme, MSc

After this workshop, participants will be able to:

  1. Evaluate frail and elderly patients with heart failure
  2. Determine the effects of frailty in heart failure patients
  3. Identify the challenges that frailty in the elderly pose with respect to heart failure treatment plans

How and when to stop cardiac medications in your heart failure patients

Elizabeth Swiggum, MD

After this workshop, participants will be able to:

  1. Understand the implications for withdrawal of evidence-based therapy in patients with recovered ejection fraction
  2. Identify clinical scenarios where withdrawal of therapy is likely to be safe
  3. Formulate a practical approach to discussing medical withdrawal with HF patients

CCS Guidelines Update: Heart failure & atrial fibrillation (in English and in French)

English: Michael McDonald, MD and Mario Talajic, MD
French: Eileen O'Meara, MD

After this workshop, participants will be able to:

  1. Define the clinical significance and risks associated with coexisting atrial fibrillation and heart failure
  2. Recognize the rhythm, rate and device considerations for patients with coexisting atrial fibrillation and heart failure
  3. Understand the recent clinical trial data featuring heart failure patients with concomitant atrial fibrillation

Contemporary palliative care in heart failure

Caroline McGuinty, MD

After this workshop, participants will be able to:

  1. Describe practical strategies for initiating a discussion on goals of care with HF patients in palliative care
  2. Review treatment options, including cannabis use, for the management of non-cardiovascular symptoms in HF patients in palliative care
  3. Discuss approaches to handle requests from HF patients for medically assisted death

Shared Care Models for heart failure: Working with primary care

Harriette Van Spall, MD
Shelley Zieroth, MD

After this workshop, participants will be able to:

  1. Review established healthcare models for the shared care of patients with HF
  2. Examine innovative strategies, including technology, for transition and community-based care of patients with HF
  3. Discuss approaches for timely access to consultative services from specialists and tools for knowledge translation

CHFS & SSVQ joint Workshop
Internal medicine and cardiology: Leveraging expertise in heart failure care (in French)

Anique Ducharme, MD
Daniel Carrier, MD
Serge Lepage, MD

After this workshop, participants will be able to:

  1. Evaluate the gap in heart failure care between internal medicine and cardiology specialties
  2. Examine ways in which cardiology can build on the clinical experience of internal medicine to improve HF care in a multimorbid setting
  3. Determine when to refer for advanced HF care

VAD or transplant for patients over 65

Phyllis Billia, MD

After this workshop, participants will be able to:

  1. Review the evidence for advanced HF therapies in older patients
  2. Identify older patients who are most likely to benefit from VAD or transplantation
  3. Examine the relative implications of de novo transplantation in older patients and re-transplantation in younger HF patients

Practical approaches to self-care management

Karen Harkness, RN, PhD
Harleah Buck, RN, PhD

After this workshop, participants will be able to:

  1. Provide an in-depth overview of factors that impact patient engagement in self-care
  2. Review practical approaches that integrate the role of family caregivers for supporting patient self-care.
  3. Discuss tips for supporting patient education and self-care engagement in challenging situations